Profiteering Laws Fail Prostate Cancer Patients

Nov. 6 (Bloomberg) -- At up to $40,000 per patient, intensity-modulated radiation therapy, or IMRT, is one of the most profitable prostate cancer treatments for urologists, while not necessarily the most effective, according to several medical studies. One in five urologists now boost their income by billing for the therapy, according to a survey by the Urology Times. Bloomberg's Kevin Thrash reports on some urologists in Monterey County, California, who are being investigated by U.S. Department of Health and Human Services for possibly putting profits ahead of patients. (Source: Bloomberg)
China's Inflation Target `Bit Too Ambitious': Qiao
30:25 - March 5 -- Helen Qiao, chief China economist at Morgan Stanley, talks about the forecasts announced by Premier Li Keqiang at the annual meeting of the legislature in Beijing. She speaks with Rishaad Salamat on Bloomberg Television's "Trending Business."
  • PBOC to Lower Rates, Has Room to Cut Reserve Ratio: Fan
  • U.S. Ambassador Attacked: What Happened & Who's to Blame?
  • Information Is the New Currency: OpenText's Howatson